Physician profile
Greg O Lund
NPI 1538169321
$2,663.40
in general payments reported to CMS, 2019-2025
15 companies · $52.27 in 2025
The $52.27 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $120 · 2020: $1,449 · 2021: $314 · 2022: $277 · 2023: $295 · 2024: $155 · 2025: $52.27.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $503.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $502.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus Corporation of The Americas | $1,448.99 | 2020 | |
| Boston Scientific Corporation | $223.68 | 2019-2022 | |
| C. R. Bard, INC. & Subsidiaries | $221.44 | 2023-2024 | Bard Urinary Drainage Bag |
| Rochester Medical Corporation | $187.02 | 2022 | |
| Laborie Medical Technologies Corp. | $120.42 | 2023-2024 | Endosheath Technology |
| Abbvie INC. | $101.82 | 2024-2025 | |
| Astellas Pharma US INC | $99.99 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $99.49 | 2021 | |
| Olympus America INC. | $49.20 | 2019 | |
| Coloplast Corp | $41.15 | 2024 | |
| Pfizer INC. | $21.18 | 2022 | |
| Novartis Pharmaceuticals Corporation | $17.80 | 2025 | |
| Lifescan, INC. | $13.99 | 2019 | |
| Janssen Biotech, INC. | $12.15 | 2019 | |
| Travere Therapeutics, INC. | $5.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Greg Lund listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.